Ultragenyx Pharmaceutical
RARE
#4102
Rank
S$3.36 B
Marketcap
S$35.61
Share price
0.18%
Change (1 day)
-41.34%
Change (1 year)

Ultragenyx Pharmaceutical (RARE) - Net assets

Net assets on the balance sheet as of March 2025 : S$0.19 Billion

According to Ultragenyx Pharmaceutical's latest financial reports the company has S$0.19 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Ultragenyx Pharmaceutical - Net assets on balance sheet (from 2012 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$S$0.35 B-1.98%
2023-12-31$S$0.36 B-23.03%
2022-12-31$S$0.47 B-62.11%
2021-12-31$S$1.24 B-18.33%
2020-12-31$S$1.52 B73.27%
2019-12-31$S$0.88 B5.95%
2018-12-31$S$0.83 B62.2%
2017-12-31$S$0.51 B-25.24%
2016-12-31$S$0.68 B-8.69%
2015-12-31$S$0.75 B207.41%
2014-12-31$S$0.24 B284.92%
2013-12-31$S$63.48 M-38.45%
2012-12-31$S$0.10 B648.3%
2011-12-31$S$13.78 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
BioMarin Pharmaceutical
BMRN
S$7.45 B 3,730.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$0.24 B 27.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-S$0.55 Billion-381.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
S$0.15 B-18.65%๐Ÿ‡บ๐Ÿ‡ธ USA